Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors
Authors:
- 7 June 2011
- book chapter
- Published by Springer Nature
- Vol. 317, 83-114
Abstract
Fragment-based drug discovery (FBDD) has become increasingly popular over the last decade. We review here how we have used highly structure-driven fragment-based approaches to complement more traditional lead discovery to tackle high priority targets and those struggling for leads. Combining biomolecular nuclear magnetic resonance (NMR), X-ray crystallography, and molecular modeling with structure-assisted chemistry and innovative biology as an integrated approach for FBDD can solve very difficult problems, as illustrated in this chapter. Here, a successful FBDD campaign is described that has allowed the development of a clinical candidate for BACE-1, a challenging CNS drug target. Crucial to this achievement were the initial identification of a ligand-efficient isothiourea fragment through target-based NMR screening and the determination of its X-ray crystal structure in complex with BACE-1, which revealed an extensive H-bond network with the two active site aspartate residues. This detailed 3D structural information then enabled the design and validation of novel, chemically stable and accessible heterocyclic acylguanidines as aspartic acid protease inhibitor cores. Structure-assisted fragment hit-to-lead optimization yielded iminoheterocyclic BACE-1 inhibitors that possess desirable molecular properties as potential therapeutic agents to test the amyloid hypothesis of Alzheimer’s disease in a clinical setting.Keywords
This publication has 110 references indexed in Scilit:
- Thermodynamics guided lead discovery and optimizationDrug Discovery Today, 2010
- Impact of linker strain and flexibility in the design of a fragment-based inhibitorNature Chemical Biology, 2009
- Two ‘Golden Ratio’ indices in fragment-based drug discoveryDrug Discovery Today, 2009
- Discovery of Highly Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase by Fragment HoppingJournal of Medicinal Chemistry, 2009
- Theoretical analysis of the competition ligand‐based NMR experiments and selected applications to fragment screening and binding constant measurementsConcepts in Magnetic Resonance Part A, 2008
- Group Efficiency: A Guideline for Hits‐to‐Leads ChemistryChemMedChem, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography studyAnnals of Neurology, 2006
- NMR-Based Screening of Proteins Containing 13C-Labeled Methyl GroupsJournal of the American Chemical Society, 2000
- BACE Maps to Chromosome 11 and a BACE Homolog, BACE2 , Reside in the Obligate Down Syndrome Region of Chromosome 21Science, 1999